Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
The CORE Buprenorphine Project - An HIV Primary Care Program Demonstration
This study is currently recruiting participants.
Study NCT00227357 Information provided by Ruth M. Rothstein CORE Center
First Received: September 27, 2005 Last Updated: March 10, 2006
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV Infections
AIDS
Opiate Dependence
Post-Traumatic Stress Disorders
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
Infection
Opioid-Related Disorders
Stress Disorders, Post-Traumatic
Stress Disorders, Traumatic
More general conditions related to this trial
Anxiety Disorders
Disorders of Environmental Origin
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Mental Disorders
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Substance-Related Disorders
Virus Diseases
Interventions listed in this trial
On-site - buprenorphine (Suboxone)
Off-site - methadone or no agonist
Additional drug interventions recognized in this trial
Buprenorphine
Methadone
More general drug interventions related to this trial
Analgesics
Analgesics, Opioid
Antitussive Agents
Central Nervous System Agents
Central Nervous System Depressants
Narcotic Antagonists
Narcotics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Ruth M. Rothstein CORE Center
Back to top of Main Content
